These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17953718)

  • 1. Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects.
    Khosravan R; Grabowski B; Wu JT; Joseph-Ridge N; Vernillet L
    Br J Clin Pharmacol; 2008 Mar; 65(3):355-63. PubMed ID: 17953718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non-purine selective inhibitor of xanthine oxidase.
    Grabowski B; Khosravan R; Wu JT; Vernillet L; Lademacher C
    Br J Clin Pharmacol; 2010 Jul; 70(1):57-64. PubMed ID: 20642548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.
    Khosravan R; Kukulka MJ; Wu JT; Joseph-Ridge N; Vernillet L
    J Clin Pharmacol; 2008 Sep; 48(9):1014-24. PubMed ID: 18635756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.
    Khosravan R; Grabowski BA; Wu JT; Joseph-Ridge N; Vernillet L
    Clin Pharmacokinet; 2006; 45(8):821-41. PubMed ID: 16884320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
    Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of febuxostat in healthy Chinese volunteers.
    Liu XX; Liu RJ; Ding L; Lin YF; Huang NY; Xiao HF; Huang Y; Yang J; Wang SL
    Arzneimittelforschung; 2012 Oct; 62(10):463-9. PubMed ID: 22956350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):17S-19S. PubMed ID: 7547087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.
    Chandra R; Liu P; Breen JD; Fisher J; Xie C; LaBadie R; Benner RJ; Benincosa LJ; Sharma A
    Clin Pharmacokinet; 2007; 46(3):247-59. PubMed ID: 17328583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
    Kubitza D; Becka M; Zuehlsdorf M; Mueck W
    J Clin Pharmacol; 2006 May; 46(5):549-58. PubMed ID: 16638738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men.
    Courtney R; Radwanski E; Lim J; Laughlin M
    Antimicrob Agents Chemother; 2004 Mar; 48(3):804-8. PubMed ID: 14982768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment.
    Mayer MD; Khosravan R; Vernillet L; Wu JT; Joseph-Ridge N; Mulford DJ
    Am J Ther; 2005; 12(1):22-34. PubMed ID: 15662289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase.
    Khosravan R; Grabowski BA; Mayer MD; Wu JT; Joseph-Ridge N; Vernillet L
    J Clin Pharmacol; 2006 Jan; 46(1):88-102. PubMed ID: 16397288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids.
    Auclair B; Nix DE; Adam RD; James GT; Peloquin CA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):810-4. PubMed ID: 11181366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs.
    Khosravan R; Wu JT; Joseph-Ridge N; Vernillet L
    J Clin Pharmacol; 2006 Aug; 46(8):855-66. PubMed ID: 16855070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of food and an antacid on the bioavailability of dexketoprofen trometamol.
    McEwen J; De Luca M; Casini A; Gich I; Barbanoj MJ; Tost D; Artigas R; Mauleón D
    J Clin Pharmacol; 1998 Dec; 38(S1):41S-45S. PubMed ID: 9882081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.
    Yasuda S; Higashi S; Murakami M; Tomono Y; Kawaguchi M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):249-53. PubMed ID: 10363624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.
    Scott G; Vinluan Reynolds C; Milosavljev S; Langholff W; Shenouda M; Rordorf C
    Clin Pharmacokinet; 2004; 43(5):341-8. PubMed ID: 15080766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.
    Yin OQ; Bédoucha V; McCulloch T; Zheng C; Zhou W; Hussaini A; Novick S
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):219-26. PubMed ID: 23070146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.